Senolytics reduce coronavirus-related mortality in old mice
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Senescent cells exacerbate COVID-19: Cellular senescence is a state elicited in response to stress signals and is associated with a damaging secretory phenotype. The number of senescent cells increases with advanced age and this in turn drives age-related diseases. Camell et al. show that senescent cells have an amplified inflammatory response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (see the Perspective by Cox and Lord). This response is communicated to nonsenescent cells, suppressing viral defense mechanisms and increasing the expression of viral entry proteins. In old mice infected with a SARS-CoV-2–related virus, treatment with senolytics to reduce the senolytic cell burden reduced mortality and increased antiviral antibodies. Science , abe4832, this issue p. eabe4832 ; see also abi4474, p. 281
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interlinked and fundamental aging processes appear to be a root-cause contributor to many disorders and diseases.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Geroscience Hypothesis holds that these pillars of aging, including cellular senescence, tend to progress in concert and may be root-cause contributors to the pathophysiology of multiple diseases”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Persistent senescent cells appear to be highly responsive to extracellular cues, such as damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs), which can exacerbate the proapoptotic, pro-inflammatory qualities of the SASP16.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SARS-CoV-2, like other viruses, can induce senescence and exacerbates the senescence-associated secretory phenotype (SASP)”
From COVID-19 and cellular senescence (2023) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, it was found that SARS-CoV-2 can evoke a form of cellular senescence, virus-induced senescence (VIS) (Box 1), through multiple mechanisms27–29”
From COVID-19 and cellular senescence (2023) · cites this paper as [27]
Experimental — accuracy not yet measured
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationAn Analysis of Transformations
Box, G. E. P., & Cox, D. R. (1964) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1964.tb00553.x · Cited by 15,052 · cited 1×
“05), we used zero-skewness log transformation (54).”
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · cited 1×
“Factors that are common components of the SASP are linked to prolonged disease, hyperinflammation/cytokine storm/acute respiratory distress syndrome (ARDS), myocarditis with troponin leak, T cell deficiencies, clotting, delirium, and multi-organ failure in SARS-CoV-2 patients (15).”
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898 · cited 1×
“However, certain inflammatory/SASP factors released by senescent human lung cell types—including IL-1 α , IL-1 β , IL-6, MCP-1, TNF α , and MMP-1—are central to the pathological cytokine storm seen in some COVID-19 patients (4, 5, 24–33).”
Comparing Individual Means in the Analysis of Variance
Tukey, J. W. (1949) · Biometrics · doi:10.2307/3001913 · Cited by 4,246 · cited 1×
“Tukey HSD test was used for post-hoc multiple-comparison after one-or two-way ANOVA (56, 57).”
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“The generation and characterization of the INK-ATTAC transgenic mouse line has been described (42).”
Self-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 1×
“Cellular senescence has emerged as one of the mechanisms that drives aging and age-related diseases that is most tractable to therapeutically target (6, 7).”
Self-citationCell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Cited by
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Self-citationSenescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794
Cellular senescence: a key therapeutic target in aging and diseases
Zhang, L., Pitcher, L. E., Yousefzadeh, M. J., Niedernhofer, L. J., Robbins, P. D., & Zhu, Y. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158450 · Cited by 631
“In addition, fisetin enhanced the immune response of old mice exposed to pathogens, including the mouse hepatitis virus, a β-coronavirus, and reduced mortality (11).”
BackgroundSelf-citationStrategies for targeting senescent cells in human disease
Gasek, N. S., Kuchel, G. A., Kirkland, J. L., & Xu, M. (2021) · Nature Aging · doi:10.1038/s43587-021-00121-8 · Cited by 501
Self-citationAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Self-citation
Metadata
- Authors
- Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., Ejima, K., Xue, A., Tripathi, U., Espindola-Netto, J. M., Giorgadze, N., Atkinson, E. J., Inman, C. L., Johnson, K. O., Cholensky, S. H., Carlson, T. W., LeBrasseur, N. K., Khosla, S., O’Sullivan, M. G., Allison, D. B., Jameson, S. C., Meves, A., Li, M., Prakash, Y. S., Chiarella, S. E., Hamilton, S. E., Tchkonia, T., Niedernhofer, L. J., Kirkland, J. L., & Robbins, P. D.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.
- Indiana University Bloomington (US)
- Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
- Corresponding author
- Camell, Christina D.
- Yousefzadeh, Matthew J.
- Zhu, Yi
- Prata, Larissa G. P. Langhi
- Hamilton, Sara E.
- Niedernhofer, Laura J.
- Kirkland, James L.
- Robbins, Paul D.
- ORCID
- Camell, Christina D.
- Yousefzadeh, Matthew J.
- Zhu, Yi
- Prata, Larissa G. P. Langhi
- Huggins, Matthew A.
- Pierson, Mark
- Zhang, Lei
- Pirtskhalava, Tamar
- Xun, Pengcheng
- Ejima, Keisuke
- Tripathi, Utkarsh
- Atkinson, Elizabeth J.
- Johnson, Kurt O.
- Carlson, Timothy W.
- LeBrasseur, Nathan K.
- Khosla, Sundeep
- O’Sullivan, M. Gerard
- Allison, David B.
- Jameson, Stephen C.
- Meves, Alexander
- Li, Ming
- Prakash, Y. S.
- Chiarella, Sergio E.
- Hamilton, Sara E.
- Tchkonia, Tamara
- Niedernhofer, Laura J.
- Kirkland, James L.
- Robbins, Paul D.
- Venue
- Science
- Published
- 2021-07-16
- Volume
- 373
- Issue
- 6552
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8607935
- OpenAlex
- W3172838821
- Cited by
- 320
- References
- 59
- Citations by year
- 2026: 32 · 2025: 51 · 2024: 55 · 2023: 57 · 2022: 81 · 2021: 44
- FWCI
- 37.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG063543-02S1, AG043376, AG056278, AG063543, AG062413, AG013925, AG058800)
- University of Minnesota Clinical and Translational Science Institute (N/A)
- Connor Fund (N/A)
- Robert J. and Theresa W. Ryan Fund (N/A)
- Noaber Foundation (N/A)
- Glenn Foundation for Medical Research (N/A)
- American Federation for Aging Research (N/A)
- American Foundation for Aging Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- senolytics, cellular senescence, SARS-CoV-2, COVID-19 mortality, aging, inflammation, pathogen-associated molecular patterns, spike protein, antiviral gene expression, paracrine signaling, antiviral antibodies, age-related diseases
- MeSH terms
- Dasatinib, Pathogen-Associated Molecular Pattern Molecules, Receptors, Coronavirus, COVID-19, COVID-19 Drug Treatment, Aging, Animals, Cell Line, Female, Gene Expression Regulation, Murine hepatitis virus, Humans, Lipopolysaccharides, Male, Mice, Inbred C57BL, Quercetin, Specific Pathogen-Free Organisms, Cellular Senescence, Coronavirus Infections, Flavonols, Mice, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Senolytics reduce coronavirus-related mortality in old mice. https://app.cochat.ai/papers/10.1126/science.abe4832
- The paper
- Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., Ejima, K., Xue, A., Tripathi, U., Espindola-Netto, J. M., Giorgadze, N., Atkinson, E. J., Inman, C. L., Johnson, K. O., Cholensky, S. H., . . . Robbins, P. D. (2021). Senolytics reduce coronavirus-related mortality in old mice. Science. https://doi.org/10.1126/science.abe4832
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.